Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Breast Cancer

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 440 articles:
HTML format

Single Articles

    January 2024
  1. BUGA A, Harper DG, Sapper TN, Hyde PN, et al
    Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial.
    PLoS One. 2024;19:e0296523.
    PubMed     Abstract available

  2. VAGNINI D, Natalucci V, Moi S, Vallorani L, et al
    Home-based lifestyle intervention for breast cancer survivors: A surprising improvement in the quality of life during the first year of COVID-19 pandemic.
    PLoS One. 2024;19:e0296163.
    PubMed     Abstract available

  3. CHEN X, Li H
    Bruceine D and Narclasine inhibit the proliferation of breast cancer cells and the prediction of potential drug targets.
    PLoS One. 2024;19:e0297203.
    PubMed     Abstract available

  4. LYONS-RAHILLY T, Meskell P, Carey E, Meade E, et al
    Exploring the experiences of women living with metastatic breast cancer [MBC]: A systematic review of qualitative evidence.
    PLoS One. 2024;19:e0296384.
    PubMed     Abstract available

  5. GAO W, Sun L, Gai J, Cao Y, et al
    Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysis.
    PLoS One. 2024;19:e0297260.
    PubMed     Abstract available

  6. MIGOWSKI A, Nadanovsky P, Manso de Mello Vianna C
    Harms and benefits of mammographic screening for breast cancer in Brazil.
    PLoS One. 2024;19:e0297048.
    PubMed     Abstract available

  7. SHAHMIRZALOU P, Rasekhi A, Jafari Khaledi M, Khayamzadeh M, et al
    Comparison performance of the Bayesian Approach with the Weibull and Birnbaum-Saunders distributions in imputation of time-to-event censors.
    PLoS One. 2024;19:e0295977.
    PubMed     Abstract available

  8. ZARIF S, Abdulkader H, Elaraby I, Alharbi A, et al
    Using hybrid pre-trained models for breast cancer detection.
    PLoS One. 2024;19:e0296912.
    PubMed     Abstract available

  9. SINKALA M, Naran K, Ramamurthy D, Mungra N, et al
    Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects.
    PLoS One. 2024;19:e0296511.
    PubMed     Abstract available

  10. PIEDRA-DELGADO L, Chambergo-Michilot D, Morante Z, Fairen C, et al
    Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience.
    PLoS One. 2024;19:e0293833.
    PubMed     Abstract available

  11. PUVVULA PK, Moon AM
    Discovery and characterization of anti-cancer peptides from a random peptide library.
    PLoS One. 2024;19:e0293072.
    PubMed     Abstract available

  12. RAGHURAM GV, Pal K, Sriram G, Khan A, et al
    Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
    PLoS One. 2024;19:e0298042.
    PubMed     Abstract available

  13. SVENDSEN SMS, Pedersen DC, Jensen BW, Aarestrup J, et al
    Early life body size and puberty markers as predictors of breast cancer risk later in life: A neural network analysis.
    PLoS One. 2024;19:e0296835.
    PubMed     Abstract available

  14. KUO ET, Kuo C, Lin CL
    Inhaled anesthesia associated with reduced mortality in patients with stage III breast cancer: A population-based study.
    PLoS One. 2024;19:e0289519.
    PubMed     Abstract available

  15. NYAMHANGA T, Eustace RW, Makoye JP, Mutalemwa K, et al
    Multi-level barriers to early detection of breast cancer among rural midlife women in Tanzania: A qualitative case study.
    PLoS One. 2024;19:e0297798.
    PubMed     Abstract available

  16. MILLER JL, Reddy A, Harman RM, Van de Walle GR, et al
    A xenotransplantation mouse model to study physiology of the mammary gland from large mammals.
    PLoS One. 2024;19:e0298390.
    PubMed     Abstract available

  17. XIA Q, Shen J, Wang Q, Chen R, et al
    Cuproptosis-associated ncRNAs predict breast cancer subtypes.
    PLoS One. 2024;19:e0299138.
    PubMed     Abstract available

  18. BAKER R, Dell'Acqua G, Richards A, Thornton MJ, et al
    Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
    PLoS One. 2024;19:e0297080.
    PubMed     Abstract available

  19. WIRANATA JA, Hutajulu SH, Astari YK, Leo B, et al
    Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer.
    PLoS One. 2024;19:e0298928.
    PubMed     Abstract available

  20. TAOMA K, Ruengjitchatchawalya M, Liangruksa M, Laomettachit T, et al
    Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy.
    PLoS One. 2024;19:e0298788.
    PubMed     Abstract available

  21. ABDUL REHMAN M, Tahir E, Ghulam Hussain H, Khalid A, et al
    Awareness regarding breast cancer amongst women in Pakistan: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298275.
    PubMed     Abstract available

  22. WAHLSTROM E, Audisio RA, Selvaggi G
    Aspects to consider regarding breast cancer risk in trans men: A systematic review and risk management approach.
    PLoS One. 2024;19:e0299333.
    PubMed     Abstract available

  23. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
    Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design.
    PLoS One. 2024;19:e0297773.
    PubMed     Abstract available

  24. NGUYEN AQ, Tran OTM, Nguyen PK, Nguyen HT, et al
    Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam.
    PLoS One. 2024;19:e0300474.
    PubMed     Abstract available

  25. NORTHGRAVES M, Cohen J, Harvey J, Huang C, et al
    A randomised controlled trial of Pre-Operative Oncotype DX testing in early-stage breast cancer (PRE-DX study) - Study protocol.
    PLoS One. 2024;19:e0300339.
    PubMed     Abstract available

  26. ZHU JJ, Huang FY, Chen H, Zhang YL, et al
    Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the Luminal A Breast Cancer.
    PLoS One. 2024;19:e0299571.
    PubMed     Abstract available

  27. BELACHEW EB, Desta AF, Mulu A, Deneke DB, et al
    High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
    PLoS One. 2024;19:e0298583.
    PubMed     Abstract available

  28. OTTO AK, Prinsloo S, Natori A, Wagner RW, et al
    Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States.
    PLoS One. 2024;19:e0297077.
    PubMed     Abstract available

  29. NIU X, Wang J, Liu J, Yu Q, et al
    17beta-Estradiol promotes metastasis in triple-negative breast cancer through the Calpain/YAP/beta-catenin signaling axis.
    PLoS One. 2024;19:e0298184.
    PubMed     Abstract available

  30. EBRAHIMPOUR-KOUJAN S, Benisi-Kohansal S, Azadbakht L, Fallah M, et al
    Adherence to HEI-2010 and odds of breast cancer according to the menopause status: Evidence from Middle Eastern Country.
    PLoS One. 2024;19:e0300986.
    PubMed     Abstract available

  31. DEMEKE T, Hailemariam D, Santos P, Seife E, et al
    Willingness and ability to pay for breast cancer treatment among patients from Addis Ababa, Ethiopia: A cross-sectional study.
    PLoS One. 2024;19:e0300631.
    PubMed     Abstract available

  32. RAGHURAM GV, Pal K, Sriram G, Khan A, et al
    Correction: Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
    PLoS One. 2024;19:e0301650.
    PubMed     Abstract available

  33. Retraction: Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
    PLoS One. 2024;19:e0300804.

  34. KANG ES, Lim YC, Jang BH, Lee YJ, et al
    Changes in lymph node surgery in breast cancer and preoperative drug prescription analysis for postoperative pain management: A retrospective, cross-sectional study.
    PLoS One. 2024;19:e0298270.
    PubMed     Abstract available

  35. FONSECA-ALVES CE, Leis-Filho AF, Lacerda ZA, de Faria Lainetti P, et al
    Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis in human and canine prostate cancer cells.
    PLoS One. 2024;19:e0297043.
    PubMed     Abstract available

  36. ZHU K, Sui Y, Zhu M, Gao Y, et al
    Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
    PLoS One. 2024;19:e0301057.
    PubMed     Abstract available

    An improved breast cancer classification with hybrid chaotic sand cat and Remora Optimization feature selection algorithm.
    PLoS One. 2024;19:e0300622.
    PubMed     Abstract available

  38. SLOJEWSKA K, Galbarczyk A, Klimek M, Tubek-Krokosz A, et al
    Higher number of steps is related to lower endogenous progesterone but not estradiol levels in women.
    PLoS One. 2024;19:e0299580.
    PubMed     Abstract available

  39. BAHCACI U, Atasavun Uysal S, Erdogan Iyigun Z, Ordu C, et al
    Progressive relaxation training in patients with breast cancer receiving aromatase inhibitor therapy-randomized controlled trial.
    PLoS One. 2024;19:e0301020.
    PubMed     Abstract available

  40. ABIDI O, Abdelkafi-Koubaa Z, Bettaieb-Dridi I, Toumi L, et al
    Pistacia lentiscus L. revealed in vitro anti-proliferative activity on MCF-7 breast cancer cells and in vivo anti-mammary cancer effect on C57BL/6 mice through necrosis, anti-inflammatory and antioxidant enhancements.
    PLoS One. 2024;19:e0301524.
    PubMed     Abstract available

  41. ERDOGAN C, Suer I, Kaya M, Ozturk S, et al
    Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network in breast cancer.
    PLoS One. 2024;19:e0301995.
    PubMed     Abstract available

  42. ALLANA A, Shamsi U, Rashid Y, Khan FR, et al
    Oral mucositis & oral health related quality of life in women undergoing chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based cross-sectional study.
    PLoS One. 2024;19:e0295456.
    PubMed     Abstract available

  43. EUM DY, Jeong M, Park SY, Kim J, et al
    AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in mouse breast cancer cells.
    PLoS One. 2024;19:e0296989.
    PubMed     Abstract available

  44. KIM BK, Kim B, You SH, Jang MS, et al
    Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging.
    PLoS One. 2024;19:e0300171.
    PubMed     Abstract available

  45. LUKASIEWICZ-SMIETANSKA D, Godlewski D, Nowakowska E, Szpak A, et al
    Association of the bitter taste genes TAS2R38 and CA6 and breast cancer risk; a case-control study of Polish women in Poland and Polish immigrants in USA.
    PLoS One. 2024;19:e0300061.
    PubMed     Abstract available

  46. LEVKOVICH I, Rosman L, Signorelli C
    "Hearing the pupils' voices through my own struggles": A qualitative study of return to work among school counselors who are breast cancer survivors.
    PLoS One. 2024;19:e0300396.
    PubMed     Abstract available

  47. BEHR M, Alizadeh L, Buckner-Baiamonte L, Roberts B, et al
    Structured illumination microscopy for cancer identification in diagnostic breast biopsies.
    PLoS One. 2024;19:e0302600.
    PubMed     Abstract available

  48. VERMEHREN-SCHMAEDICK A, Peto M, Wagoner W, Chiotti KE, et al
    Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.
    PLoS One. 2024;19:e0302856.
    PubMed     Abstract available

  49. KAWAZU M, Saso K, Tong KI, McQuire T, et al
    Correction: Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development.
    PLoS One. 2024;19:e0303780.
    PubMed     Abstract available

  50. SCHWARZ F, Arefian H, Hartmann M, Runnebaum I, et al
    Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
    PLoS One. 2024;19:e0303776.
    PubMed     Abstract available

  51. SUN G, Cai L, Yan X, Nie W, et al
    A prediction model based on digital breast pathology image information.
    PLoS One. 2024;19:e0294923.
    PubMed     Abstract available

  52. PELICANO AC, Goncalves MCT, Castela T, Orvalho ML, et al
    Repository of MRI-derived models of the breast with single and multiple benign and malignant tumors for microwave imaging research.
    PLoS One. 2024;19:e0302974.
    PubMed     Abstract available

  53. YANG Z, Wang Y, Huang S, Geng Y, et al
    Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in Breast cancer.
    PLoS One. 2024;19:e0303650.
    PubMed     Abstract available

  54. PINTO-CARBO M, Vanaclocha-Espi M, Ibanez J, Martin-Pozuelo J, et al
    Interaction of sedentary behaviour and educational level in breast cancer risk.
    PLoS One. 2024;19:e0300349.
    PubMed     Abstract available

  55. SAITO N, Matsuo T, Tsuda H, Yokota H, et al
    Novel approach to HER2 quantification using phosphor-integrated dots in human breast invasive cancer microarray.
    PLoS One. 2024;19:e0303614.
    PubMed     Abstract available

  56. XIAO J, Tan L, Pei Y, Yang R, et al
    Association between red cell distribution width and all-cause mortality in patients with breast cancer: A retrospective analysis using MIMIC-IV 2.0.
    PLoS One. 2024;19:e0302414.
    PubMed     Abstract available

  57. MUNTER-YOUNG R, Fuentes-Alburo A, DiGregorio N, Neeser K, et al
    Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.
    PLoS One. 2024;19:e0302486.
    PubMed     Abstract available

  58. XU Y, Yu J, Shen R, Shan X, et al
    Comparison efficacy and safety of acupuncture and moxibustion therapies in breast cancer-related lymphedema: A systematic review and network meta-analysis.
    PLoS One. 2024;19:e0303513.
    PubMed     Abstract available

  59. LUU TNN, Dinh DX, Tran TX, Tran TB, et al
    Health-state utility of patients with HER2-positive breast cancer in Vietnam: A multicenter cross-sectional study.
    PLoS One. 2024;19:e0303011.
    PubMed     Abstract available

  60. KIM SM, Park N, Park HB, Lee J, et al
    Exploring novel immunotherapy biomarker candidates induced by cancer deformation.
    PLoS One. 2024;19:e0303433.
    PubMed     Abstract available

    January 2023
  61. DAMMU H, Ren T, Duong TQ
    Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients.
    PLoS One. 2023;18:e0280148.
    PubMed     Abstract available

  62. YUAN Y, Liu X, Cai Y, Li W, et al
    Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review.
    PLoS One. 2023;18:e0279775.
    PubMed     Abstract available

  63. ISLAM N, Bhuiyan AKMMR, Alam A, Chowdhury MK, et al
    Coping strategy among the women with metastatic breast cancer attending a palliative care unit of a tertiary care hospital of Bangladesh.
    PLoS One. 2023;18:e0278620.
    PubMed     Abstract available

  64. Retraction: Synthesis, Characterization and In Vitro Study of Biocompatible Cinnamaldehyde Functionalized Magnetite Nanoparticles (CPGF Nps) For Hyperthermia and Drug Delivery Applications in Breast Cancer.
    PLoS One. 2023;18:e0280492.

  65. HU G, Ding Q, Zhong K, Wang S, et al
    Low pretreatment prognostic nutritional index predicts poor survival in breast cancer patients: A meta-analysis.
    PLoS One. 2023;18:e0280669.
    PubMed     Abstract available

  66. ZHENG H, Ge C, Lin H, Zhou S, et al
    The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups.
    PLoS One. 2023;18:e0280474.
    PubMed     Abstract available

  67. FLOOD E, Krasnow A, Orbegoso C, Karantzoulis S, et al
    Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancer.
    PLoS One. 2023;18:e0280259.
    PubMed     Abstract available

  68. SYED A, Adam R, Ren T, Lu J, et al
    Machine learning with textural analysis of longitudinal multiparametric MRI and molecular subtypes accurately predicts pathologic complete response in patients with invasive breast cancer.
    PLoS One. 2023;18:e0280320.
    PubMed     Abstract available

  69. JANG SJ, Moon C
    Aquaporin 5 (AQP5) expression in breast cancer and its clinicopathological characteristics.
    PLoS One. 2023;18:e0270752.
    PubMed     Abstract available

  70. NORMANN LS, Haugen MH, Hongisto V, Aure MR, et al
    High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.
    PLoS One. 2023;18:e0280507.
    PubMed     Abstract available

  71. WU R, Luo J, Wan H, Zhang H, et al
    Evaluation of machine learning algorithms for the prognosis of breast cancer from the Surveillance, Epidemiology, and End Results database.
    PLoS One. 2023;18:e0280340.
    PubMed     Abstract available

  72. MISGANAW M, Zeleke H, Mulugeta H, Assefa B, et al
    Mortality rate and predictors among patients with breast cancer at a referral hospital in northwest Ethiopia: A retrospective follow-up study.
    PLoS One. 2023;18:e0279656.
    PubMed     Abstract available

  73. HE Y, Chen S, Gao X, Fu L, et al
    Robustness of VMAT to setup errors in postmastectomy radiotherapy of left-sided breast cancer: Impact of bolus thickness.
    PLoS One. 2023;18:e0280456.
    PubMed     Abstract available

  74. WESTHOFF CC, Muller SK, Jank P, Kalder M, et al
    Nodal lymphangiogenesis and immunophenotypic variations of sinus endothelium in sentinel and non-sentinel lymph nodes of invasive breast carcinoma.
    PLoS One. 2023;18:e0280936.
    PubMed     Abstract available

  75. YAN B, Shi R, Lu YY, Fang DD, et al
    Shenqi Fuzheng injection reverses M2 macrophage-mediated cisplatin resistance through the PI3K pathway in breast cancer.
    PLoS One. 2023;18:e0279752.
    PubMed     Abstract available

  76. LOPEZ-PANISELLO MB, Perez-Lacasta MJ, Rue M, Carles-Lavila M, et al
    Factors influencing intention to participate in breast cancer screening. An exploratory structural model.
    PLoS One. 2023;18:e0281454.
    PubMed     Abstract available

  77. LIU R, Ospanova S, Perry RJ
    The impact of variance in carnitine palmitoyltransferase-1 expression on breast cancer prognosis is stratified by clinical and anthropometric factors.
    PLoS One. 2023;18:e0281252.
    PubMed     Abstract available

  78. DHAKAL R, Adhikari C, Karki P, Neupane N, et al
    Attitude sustains longer than subjective norm and perceived behavioral control: Results of breast cancer screening educational intervention.
    PLoS One. 2023;18:e0281184.
    PubMed     Abstract available

  79. RODRIGUEZ IJ, Bernal-Estevez DA, Llano-Leon M, Bonilla CE, et al
    Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients.
    PLoS One. 2023;18:e0280851.
    PubMed     Abstract available

  80. JAYASEKERA LP, Ranasinghe R, Senathilake KS, Kotelawala JT, et al
    Mitochondrial genome in sporadic breast cancer: A case control study and a proteomic analysis in a Sinhalese cohort from Sri Lanka.
    PLoS One. 2023;18:e0281620.
    PubMed     Abstract available

  81. BOUCHMAA N, Ben Mrid R, Bouargalne Y, Ajouaoi S, et al
    In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer.
    PLoS One. 2023;18:e0272781.
    PubMed     Abstract available

  82. DELGADO AB, Tylden ES, Lukic M, Moi L, et al
    Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study.
    PLoS One. 2023;18:e0281218.
    PubMed     Abstract available

  83. MAPANGA W, Norris SA, Craig A, Ayeni OA, et al
    Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort.
    PLoS One. 2023;18:e0281916.
    PubMed     Abstract available

  84. ALMEIDA SS, Oliveira MA, Medeiros R, Guerra MP, et al
    Emotional, inflammatory, and genetic factors of resilience and vulnerability to depression in patients with premenopausal breast cancer: A longitudinal study protocol.
    PLoS One. 2023;18:e0279344.
    PubMed     Abstract available

  85. GONG W, Fang P, Leng M, Shi Y, et al
    Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 / Taxol cells.
    PLoS One. 2023;18:e0282244.
    PubMed     Abstract available

  86. LESER C, Dorffner G, Marhold M, Rutter A, et al
    Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective study.
    PLoS One. 2023;18:e0278454.
    PubMed     Abstract available

  87. PADAMSEE TJ, Muraveva A, Meadows RJ, Hils M, et al
    Racial differences in prevention decision making among U.S. women at high risk of breast cancer: A qualitative study.
    PLoS One. 2023;18:e0278742.
    PubMed     Abstract available

  88. FROST CJ, Ramirez-Mata A, Khattri RB, Merritt ME, et al
    Effects of beta-caryophyllene and oxygen availability on cholesterol and fatty acids in breast cancer cells.
    PLoS One. 2023;18:e0281396.
    PubMed     Abstract available

  89. LI Z, Wang Q, Xu J, Song Q, et al
    Comparative efficacy and acceptability of interventions for insomnia in breast cancer patients: A protocol for systematic review and network meta-analysis.
    PLoS One. 2023;18:e0282614.
    PubMed     Abstract available

  90. SHITA A, Yalew AW, Seife E, Afework T, et al
    Survival and predictors of breast cancer mortality in South Ethiopia: A retrospective cohort study.
    PLoS One. 2023;18:e0282746.
    PubMed     Abstract available

  91. SCHOUSTRA SM, De Santi B, Op 't Root TJPM, Klazen CAH, et al
    Imaging breast malignancies with the Twente Photoacoustic Mammoscope 2.
    PLoS One. 2023;18:e0281434.
    PubMed     Abstract available

  92. LIU P, Roberts S, Shoemaker JT, Vukasinovic J, et al
    Validation of a 3D perfused cell culture platform as a tool for humanised preclinical drug testing in breast cancer using established cell lines and patient-derived tissues.
    PLoS One. 2023;18:e0283044.
    PubMed     Abstract available

  93. ALMESHARI M, Alzamil Y, Alyahyawi A, Abanomy A, et al
    Awareness level, knowledge and attitude towards breast cancer among staff and students of Hail University, Saudi Arabia.
    PLoS One. 2023;18:e0282916.
    PubMed     Abstract available

  94. Retraction: Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation.
    PLoS One. 2023;18:e0283354.

  95. ROCHE S, Gaule P, Winrow D, Mukherjee N, et al
    Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer.
    PLoS One. 2023;18:e0282512.
    PubMed     Abstract available

  96. CHEN R, Li P, Fu Y, Wu Z, et al
    Chaperone-mediated autophagy promotes breast cancer angiogenesis via regulation of aerobic glycolysis.
    PLoS One. 2023;18:e0281577.
    PubMed     Abstract available

  97. PARKER G, Hunter S, Ghazi S, Hayeems RZ, et al
    Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review.
    PLoS One. 2023;18:e0280582.
    PubMed     Abstract available

  98. LEE JJ, Choi HR, Choi EP, Ho MH, et al
    Psychometric evaluation of Korean version of COVID-19 fear scale (K-FS-8): A population based cross-sectional study.
    PLoS One. 2023;18:e0282589.
    PubMed     Abstract available

  99. Retraction: Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-kappaB Activation.
    PLoS One. 2023;18:e0283750.

  100. LEHTONEN AJ, Arasalo O, Srbova L, Heilala M, et al
    Magnetic microrheometry of tumor-relevant stiffness levels and probabilistic quantification of viscoelasticity differences inside 3D cell culture matrices.
    PLoS One. 2023;18:e0282511.
    PubMed     Abstract available

  101. GORDON JAR, Evans MF, Ghule PN, Lee K, et al
    Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients.
    PLoS One. 2023;18:e0282473.
    PubMed     Abstract available

  102. CHEN J
    Timed hazard networks: Incorporating temporal difference for oncogenetic analysis.
    PLoS One. 2023;18:e0283004.
    PubMed     Abstract available

  103. MADISON AA, Filatov M, Andridge R, Haas G, et al
    A troubled heart: Mood disorder history longitudinally predicts faster cardiopulmonary aging in breast cancer survivorship.
    PLoS One. 2023;18:e0283849.
    PubMed     Abstract available

  104. ODA H, Hedayati E, Lindstrom A, Shabo I, et al
    GATA-3 expression in breast cancer is related to intratumoral M2 macrophage infiltration and tumor differentiation.
    PLoS One. 2023;18:e0283003.
    PubMed     Abstract available

  105. THIESEN AP, Mielczarski B, Savaris RF
    Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer.
    PLoS One. 2023;18:e0282176.
    PubMed     Abstract available

  106. YU J, Gao Y, Wang H, Liu B, et al
    Structural equation modeling analysis of determinants of barriers to breast self-examination among Eastern Chinese women.
    PLoS One. 2023;18:e0283525.
    PubMed     Abstract available

  107. DING L, Yang Y, Chi M, Chen Z, et al
    Diagnostic role of heart rate variability in breast cancer and its relationship with peripheral serum carcinoembryonic antigen.
    PLoS One. 2023;18:e0282221.
    PubMed     Abstract available

  108. RAAT EM, Evans KK
    Early signs of cancer present in the fine detail of mammograms.
    PLoS One. 2023;18:e0282872.
    PubMed     Abstract available

  109. SU Z, Niazi MKK, Tavolara TE, Niu S, et al
    BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images.
    PLoS One. 2023;18:e0283562.
    PubMed     Abstract available

  110. VASSILEV I, Lin SX, Calman L, Turner J, et al
    The role of social networks in the self-management support for young women recently diagnosed with breast cancer.
    PLoS One. 2023;18:e0282183.
    PubMed     Abstract available

  111. PAGE LL, Kahn CJ, Severson J, Kramer AF, et al
    Physical activity and cognitive function: A comparison of rural and urban breast cancer survivors.
    PLoS One. 2023;18:e0284189.
    PubMed     Abstract available

  112. ASLAM A, Arshad Z, Ahmed A, Soh CL, et al
    Bilateral risk-reducing mastectomy and reconstruction-A 12-year review of methodological trends and outcomes at a tertiary referral centre.
    PLoS One. 2023;18:e0281601.
    PubMed     Abstract available

  113. Retraction: Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3.
    PLoS One. 2023;18:e0284594.

  114. LLANO-LEON M, Martinez-Enriquez LC, Rodriguez-Bohorquez OM, Velandia-Vargas EA, et al
    Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0277714.
    PubMed     Abstract available

  115. CARVALHO SM, Andrade CA, Ferreira MBLS, de Souza KSS, et al
    Women's perception about the discovery of breast cancer amid the covid-19 pandemic.
    PLoS One. 2023;18:e0282610.
    PubMed     Abstract available

  116. WESTERN B, Demmelmaier I, Vistad I, Hansen BH, et al
    How many days of continuous physical activity monitoring reliably represent time in different intensities in cancer survivors.
    PLoS One. 2023;18:e0284881.
    PubMed     Abstract available

  117. BO MC, Merlo A, Ligabue MB, Bassi MC, et al
    Self-managed physical activity in breast cancer survivors: A scoping review.
    PLoS One. 2023;18:e0284807.
    PubMed     Abstract available

  118. XU H, Shao X, Hui S, Jin L, et al
    Supervised breast cancer prediction using integrated dimensionality reduction convolutional neural network.
    PLoS One. 2023;18:e0282350.
    PubMed     Abstract available

  119. SHARMA D, Tarapacki CM, Kandavel H, Panchalingam M, et al
    Evaluating the effects of radiation and acoustically-stimulated microbubble therapy in an in vivo breast cancer model.
    PLoS One. 2023;18:e0277759.
    PubMed     Abstract available

  120. BATES-FRASER LC, Riley S, Stopforth C, Moertl K, et al
    Home-based exercise improves quality of life in breast and prostate cancer survivors: A meta-analysis.
    PLoS One. 2023;18:e0284427.
    PubMed     Abstract available

  121. HIATT RA, Worden L, Rehkopf D, Engmann N, et al
    A complex systems model of breast cancer etiology: The Paradigm II Model.
    PLoS One. 2023;18:e0282878.
    PubMed     Abstract available

  122. AMER NN, Khairat R, Hammad AM, Kamel MM, et al
    DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer.
    PLoS One. 2023;18:e0284455.
    PubMed     Abstract available

  123. BEN REKAYA M, Sassi F, Saied E, Bel Haj Kacem L, et al
    PIK3CA mutations in breast cancer: A Tunisian series.
    PLoS One. 2023;18:e0285413.
    PubMed     Abstract available

  124. JI X, Li R, Hu X, Tian Y, et al
    Construction of model animals to explore intestinal microbiome for detection of breast cancer.
    PLoS One. 2023;18:e0280971.
    PubMed     Abstract available

  125. ZHUANG L, Chen Q, Chen H, Zheng X, et al
    Breast cancer-related lymphedema and recurrence of breast cancer: Protocol for a prospective cohort study in China.
    PLoS One. 2023;18:e0285772.
    PubMed     Abstract available

  126. STOCKER A, Mehnert-Theuerkauf A, Hinz A, Ernst J, et al
    Utilization of complementary and alternative medicine (CAM) by women with breast cancer or gynecological cancer.
    PLoS One. 2023;18:e0285718.
    PubMed     Abstract available

  127. ARAMAKI S, Tsuge S, Islam A, Eto F, et al
    Lipidomics-based tissue heterogeneity in specimens of luminal breast cancer revealed by clustering analysis of mass spectrometry imaging: A preliminary study.
    PLoS One. 2023;18:e0283155.
    PubMed     Abstract available

  128. MUSHEYEV D, Miller E, Birnbaum N, Miller E, et al
    Inhibition of ERK signaling for treatment of ERRalpha positive TNBC.
    PLoS One. 2023;18:e0283047.
    PubMed     Abstract available

  129. WISESTY UN, Mengko TR, Purwarianti A, Pancoro A, et al
    Temporal convolutional network for a Fast DNA mutation detection in breast cancer data.
    PLoS One. 2023;18:e0285981.
    PubMed     Abstract available

  130. Expression of Concern: MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis.
    PLoS One. 2023;18:e0286445.

  131. WU X, Wabitsch M, Yang J, Sakharkar MK, et al
    Effects of adipocyte-conditioned cell culture media on S1P treatment of human triple-negative breast cancer cells.
    PLoS One. 2023;18:e0286111.
    PubMed     Abstract available

  132. SHIBAHARA T, Wada C, Yamashita Y, Fujita K, et al
    Deep learning generates custom-made logistic regression models for explaining how breast cancer subtypes are classified.
    PLoS One. 2023;18:e0286072.
    PubMed     Abstract available

  133. ALANAZI SM, Feroz W, Mishra R, Kilroy MK, et al
    HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
    PLoS One. 2023;18:e0285251.
    PubMed     Abstract available

  134. KWAN JM, Arbune A, Henry ML, Hu R, et al
    Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients.
    PLoS One. 2023;18:e0286364.
    PubMed     Abstract available

  135. JAAMOUR A, Myles C, Patel A, Chen SJ, et al
    A divide and conquer approach to maximise deep learning mammography classification accuracies.
    PLoS One. 2023;18:e0280841.
    PubMed     Abstract available

  136. DA SILVA BR, Rufato S, Mialich MS, Cruz LP, et al
    Phase angle is related to oxidative stress and antioxidant biomarkers in breast cancer patients undergoing chemotherapy.
    PLoS One. 2023;18:e0283235.
    PubMed     Abstract available

  137. VAINER G, Huang L, Emancipator K, Nuti S, et al
    Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
    PLoS One. 2023;18:e0285764.
    PubMed     Abstract available

  138. B K M, Kaphle HP
    Breast self-examination: Knowledge, practice and associated factors among 20 to 49 years aged women in Butwal sub-metropolitan, Rupandehi, Nepal.
    PLoS One. 2023;18:e0286676.
    PubMed     Abstract available

  139. OMISORE AD, Olasehinde O, Wuraola FO, Sutton EJ, et al
    Improving access to breast cancer screening and treatment in Nigeria: The triple mobile assessment and patient navigation model (NCT05321823): A study protocol.
    PLoS One. 2023;18:e0284341.
    PubMed     Abstract available

  140. ENGEL S, Jacobsen HB, Reme SE
    A cross-sectional study of fear of surgery in female breast cancer patients: Prevalence, severity, and sources, as well as relevant differences among patients experiencing high, moderate, and low fear of surgery.
    PLoS One. 2023;18:e0287641.
    PubMed     Abstract available

  141. SHAFIK N, Ilmonen P, Viitasaari L, Sarkeala T, et al
    Flexible transition probability model for assessing cost-effectiveness of breast cancer screening extension to include women aged 45-49 and 70-74.
    PLoS One. 2023;18:e0287486.
    PubMed     Abstract available

  142. YANG Q, Li F, Jia G, Liu R, et al
    Aged black garlic extract inhibits the growth of estrogen receptor-positive breast cancer cells by downregulating MCL-1 expression through the ROS-JNK pathway.
    PLoS One. 2023;18:e0286454.
    PubMed     Abstract available

  143. SHIN KH, Ah YM, Cha SH, Choi HD, et al
    Drug-Drug interactions of docetaxel in patients with breast cancer based on insurance claims data.
    PLoS One. 2023;18:e0287382.
    PubMed     Abstract available

  144. REN Z, Easley TO, Pineda FD, Guo X, et al
    Pharmacokinetic Analysis of Enhancement-Constrained Acceleration (ECA) reconstruction-based high temporal resolution breast DCE-MRI.
    PLoS One. 2023;18:e0286123.
    PubMed     Abstract available

  145. SKJERVOLD AH, Valla M, Ytterhus B, Bofin AM, et al
    PAK1 copy number in breast cancer-Associations with proliferation and molecular subtypes.
    PLoS One. 2023;18:e0287608.
    PubMed     Abstract available

  146. LEE KH, Hwang HJ, Im YJ, Nam AR, et al
    New oncogenic functions of LINE1 retroelement as a ceRNA for tumor suppressive microRNA miR-126 on ENPP5.
    PLoS One. 2023;18:e0286814.
    PubMed     Abstract available

  147. NG B, Puspitaningtyas H, Wiranata JA, Hutajulu SH, et al
    Breast cancer incidence in Yogyakarta, Indonesia from 2008-2019: A cross-sectional study using trend analysis and geographical information system.
    PLoS One. 2023;18:e0288073.
    PubMed     Abstract available

  148. LESLIE A, Teh E, Druker A, Pinto DM, et al
    A targeted isotope dilution mass spectrometry assay for osteopontin quantification in plasma of metastatic breast cancer patients.
    PLoS One. 2023;18:e0281491.
    PubMed     Abstract available

  149. CAREDDA E, Pedini G, D'Amico F, Scioli MG, et al
    FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis.
    PLoS One. 2023;18:e0287062.
    PubMed     Abstract available

  150. SUN G, Yan X, Wang H, Li F, et al
    Color restoration based on digital pathology image.
    PLoS One. 2023;18:e0287704.
    PubMed     Abstract available

  151. MASSEY S, Khan MA, Rab SO, Mustafa S, et al
    Evaluating the role of MEN1 gene expression and its clinical significance in breast cancer patients.
    PLoS One. 2023;18:e0288482.
    PubMed     Abstract available

  152. COSAR R, Sut N, Topaloglu S, Tastekin E, et al
    Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer.
    PLoS One. 2023;18:e0283445.
    PubMed     Abstract available

  153. MANSOOR Q, Ismail M, Ali Ul Qader S
    Linkage disequilibrium block single-nucleotide polymorphisms in FTO alpha ketoglutarate dependent dioxygenase gene inference with breast cancer and Type II diabetes in Pakistani female population.
    PLoS One. 2023;18:e0288934.
    PubMed     Abstract available

  154. SAWMYNADEN K, Wong N, Davies S, Cowan R, et al
    Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool.
    PLoS One. 2023;18:e0288259.
    PubMed     Abstract available

  155. HSU SW, Chiang SC, Hsu JC, Ko Y, et al
    Prescription patterns of granulocyte colony-stimulating factors in patients with breast cancer: A real-world study.
    PLoS One. 2023;18:e0288642.
    PubMed     Abstract available

  156. SANCHEZ-BAYUELA DA, Ghavami N, Tiberi G, Sani L, et al
    A multicentric, single arm, prospective, stratified clinical investigation to evaluate MammoWave's ability in breast lesions detection.
    PLoS One. 2023;18:e0288312.
    PubMed     Abstract available

  157. LEE YJ, Yoo TK, Kim J, Chung IY, et al
    Survival outcomes of breast cancer patients with recurrence after surgery according to period and subtype.
    PLoS One. 2023;18:e0284460.
    PubMed     Abstract available

  158. FISCON G, Funari A, Paci P
    Circular RNA mediated gene regulation in human breast cancer: A bioinformatics analysis.
    PLoS One. 2023;18:e0289051.
    PubMed     Abstract available

  159. JAVAN BIPARVA A, Raoofi S, Rafiei S, Masoumi M, et al
    Global depression in breast cancer patients: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0287372.
    PubMed     Abstract available

  160. FANG Q, Xin W, Chen L, Fu Y, et al
    Caffeic acid phenethyl ester suppresses metastasis of breast cancer cells by inactivating FGFR1 via MD2.
    PLoS One. 2023;18:e0289031.
    PubMed     Abstract available

  161. OZ M, King JR, Yang KS, Khushaish S, et al
    alpha7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling.
    PLoS One. 2023;18:e0289098.
    PubMed     Abstract available

  162. NICKEL B, McCaffery K, Jansen J, Barratt A, et al
    Women's views about current and future management of Ductal Carcinoma in Situ (DCIS): A mixed-methods study.
    PLoS One. 2023;18:e0288972.
    PubMed     Abstract available

  163. LIN C, He J, Tong X, Song L, et al
    Copper homeostasis-associated gene PRNP regulates ferroptosis and immune infiltration in breast cancer.
    PLoS One. 2023;18:e0288091.
    PubMed     Abstract available

  164. KAIDAR-PERSON O, Antunes M, Cardoso JS, Ciani O, et al
    Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient's satisfaction with therapy: The CINDERELLA trial.
    PLoS One. 2023;18:e0289365.
    PubMed     Abstract available

  165. CHEN C, Wang R, Wang B, Wu Y, et al
    The effect of adjuvant radiotherapy after breast-conserving surgery in elderly women with T1-2N0 estrogen receptor-negative breast cancer.
    PLoS One. 2023;18:e0288078.
    PubMed     Abstract available

  166. GHEMRAWI R, Al Qassem A, Ramadan A, Aldulaymi R, et al
    DNA and protein methyltransferases inhibition by adenosine dialdehyde reduces the proliferation and migration of breast and lung cancer cells by downregulating autophagy.
    PLoS One. 2023;18:e0288791.
    PubMed     Abstract available

  167. XU C, Lu P, Pfob A, Pusic AL, et al
    Physical well-being recovery trajectories by reconstruction modality in women undergoing mastectomy and breast reconstruction: Significant predictors and health-related quality of life outcomes.
    PLoS One. 2023;18:e0289182.
    PubMed     Abstract available

  168. DURRANI IA, Bhatti A, John P
    Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health.
    PLoS One. 2023;18:e0289839.
    PubMed     Abstract available

  169. LEE H, Jung S, Gong G, Lim B, et al
    Association of cyclooxygenase-2 expression with endoplasmic reticulum stress and autophagy in triple-negative breast cancer.
    PLoS One. 2023;18:e0289627.
    PubMed     Abstract available

  170. LEE YW, Ahn SH, Lee YJ, Yoo TK, et al
    Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer.
    PLoS One. 2023;18:e0290174.
    PubMed     Abstract available

  171. SIBEONI J, Manolios E, Mathe J, Feka V, et al
    The experience of a program combining two complementary therapies for women with breast cancer: An IPSE qualitative study.
    PLoS One. 2023;18:e0285617.
    PubMed     Abstract available

  172. DING J, Li C, Shu K, Chen W, et al
    Membrane metalloendopeptidase (MME) is positively correlated with systemic lupus erythematosus and may inhibit the occurrence of breast cancer.
    PLoS One. 2023;18:e0289960.
    PubMed     Abstract available

  173. FERNANDEZ-GUALDA MA, Ariza-Vega P, Lozano-Lozano M, Cantarero-Villanueva I, et al
    Persistent pain management in an oncology population through pain neuroscience education, a multimodal program: PaiNEd randomized clinical trial protocol.
    PLoS One. 2023;18:e0290096.
    PubMed     Abstract available

  174. SHOAIB TH, Ibraheem W, Abdelrahman M, Osman W, et al
    Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies.
    PLoS One. 2023;18:e0289887.
    PubMed     Abstract available

  175. WANG D, Gao L, Gao X, Wang C, et al
    Identification of monotonically expressed long non-coding RNA signatures for breast cancer using variational autoencoders.
    PLoS One. 2023;18:e0289971.
    PubMed     Abstract available

  176. FLECK JL, Hooijenga D, Phan R, Xie X, et al
    Adjuvant therapeutic strategy decision support for an elderly population with localized breast cancer: A monocentric cohort retrospective study.
    PLoS One. 2023;18:e0290566.
    PubMed     Abstract available

  177. SHI D, Liang X, Li Y, Chen L, et al
    Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer.
    PLoS One. 2023;18:e0290507.
    PubMed     Abstract available

  178. NOR S, Chan KG, Rahman HA, H Abdul-Mumin K, et al
    Patient satisfaction of breast reconstructive surgery following mastectomy in Brunei.
    PLoS One. 2023;18:e0289955.
    PubMed     Abstract available

  179. GONG M, Shen F, Li Y, Ming L, et al
    MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
    PLoS One. 2023;18:e0290462.
    PubMed     Abstract available

  180. CUI Y, Lu W, Shao T, Zhuo Z, et al
    Severe mental illness and the risk of breast cancer: A two-sample, two-step multivariable Mendelian randomization study.
    PLoS One. 2023;18:e0291006.
    PubMed     Abstract available

  181. NADEEM H, Romley JA, Warren Andersen S
    Reduced racial disparity in receipt of optimal locoregional treatment for women with early-stage breast cancer.
    PLoS One. 2023;18:e0291025.
    PubMed     Abstract available

  182. AL-KAFAJI G, Jassim G, AlHajeri A, Alawadhi AMT, et al
    Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel.
    PLoS One. 2023;18:e0291015.
    PubMed     Abstract available

  183. AB MUMIN N, Ramli Hamid MT, Abdul Hamid S, Chiew SF, et al
    Magnetic resonance imaging features of invasive breast cancer association with the tumour stromal ratio.
    PLoS One. 2023;18:e0290772.
    PubMed     Abstract available

  184. MAZUMDER H, Husain M, Hossain MF, Mahmud S, et al
    Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001-2018.
    PLoS One. 2023;18:e0290994.
    PubMed     Abstract available

  185. BULUT G, Atilgan HI, Cinarer G, Kilic K, et al
    Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with 18F-FDG PET/CT.
    PLoS One. 2023;18:e0290543.
    PubMed     Abstract available

  186. SOHAIL S, Burns MB
    Integrating current analyses of the breast cancer microbiome.
    PLoS One. 2023;18:e0291320.
    PubMed     Abstract available

  187. YOUSIF FA, Alzain AA, Alraih AM, Ibraheem W, et al
    Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
    PLoS One. 2023;18:e0291256.
    PubMed     Abstract available

  188. SCHOENHALS S, Mali ME, Sutherland EK, Sorenson J, et al
    Geospatial availability of breast cancer treatment modalities and hypothetical access improvement in Ghana: A nationwide survey.
    PLoS One. 2023;18:e0291454.
    PubMed     Abstract available

  189. LAFI Z, Alshaer W, Gharaibeh L, Alqudah DA, et al
    Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line.
    PLoS One. 2023;18:e0291981.
    PubMed     Abstract available

  190. CHAU OW, El-Sherif O, Mouawad M, Sykes JM, et al
    Changes in myocardial blood flow in a canine model of left sided breast cancer radiotherapy.
    PLoS One. 2023;18:e0291854.
    PubMed     Abstract available

  191. XIA YT, Zhang YQ, Chen L, Min L, et al
    Suppression of migration and invasion by taraxerol in the triple-negative breast cancer cell line MDA-MB-231 via the ERK/Slug axis.
    PLoS One. 2023;18:e0291693.
    PubMed     Abstract available

  192. AKASH S, Aovi FI, Azad MAK, Kumer A, et al
    A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
    PLoS One. 2023;18:e0283271.
    PubMed     Abstract available

  193. RAMSHANKAR G, Liu R, Perry RJ
    The association between the amino acid transporter LAT1, tumor immunometabolic and proliferative features and menopausal status in breast cancer.
    PLoS One. 2023;18:e0292678.
    PubMed     Abstract available

  194. NDINGURI M, Middleton L, Unrine J, Lui S, et al
    Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer.
    PLoS One. 2023;18:e0287151.
    PubMed     Abstract available

  195. CABARCAS-PETROSKI S, Olshefsky G, Schramm L
    MAF1 is a predictive biomarker in HER2 positive breast cancer.
    PLoS One. 2023;18:e0291549.
    PubMed     Abstract available

  196. SCHLIEMANN D, Jamil ASA, Mohan D, Tan MM, et al
    The development and evaluation of a mHealth, community education and navigation intervention to improve clinical breast examination uptake in Segamat Malaysia: A randomised controlled trial.
    PLoS One. 2023;18:e0288437.
    PubMed     Abstract available

  197. GAO X, Zhang F, Zhou Q, Xu H, et al
    Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.
    PLoS One. 2023;18:e0293830.
    PubMed     Abstract available

  198. ZHOU H, Cai Z, Yang Q, Yang X, et al
    Inflammatory cytokines and two subtypes of breast cancer: A two-sample mendelian randomization study.
    PLoS One. 2023;18:e0293230.
    PubMed     Abstract available

  199. BOJANIC C, Di Pace B, Ghorra DT, Fopp LJ, et al
    A comparison of presentations and outcomes of salvage versus non-salvage abdominal free flap breast reconstructions-Results of a 15-year tertiary referral centre review.
    PLoS One. 2023;18:e0288364.
    PubMed     Abstract available

  200. FERREIRA HNC, Capistrano GN, Morais TNB, Costa KTDS, et al
    Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
    PLoS One. 2023;18:e0278011.
    PubMed     Abstract available

  201. PARK SY, Park JM, Kim JI, Choi CH, et al
    Quantitative radiomics approach to assess acute radiation dermatitis in breast cancer patients.
    PLoS One. 2023;18:e0293071.
    PubMed     Abstract available

  202. DA SILVA SA R, Von Ah Rodrigues RF, Bugalho LA, da Silva SU, et al
    Evaluation of the efficacy of using indocyanine green associated with fluorescence in sentinel lymph node biopsy.
    PLoS One. 2023;18:e0273886.
    PubMed     Abstract available

  203. SARTORETTI E, Largiader S, Sartoretti T, Laures S, et al
    Understanding the needs of women undergoing breast ultrasound: Are male radiologists still needed?
    PLoS One. 2023;18:e0291007.
    PubMed     Abstract available

  204. JEANMARD N, Bissanum R, Sriplung H, Charoenlappanit S, et al
    Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women.
    PLoS One. 2023;18:e0291574.
    PubMed     Abstract available

  205. MAGARA MS, Mungazi SG, Gonde P, Nare H, et al
    Factors leading to the late diagnosis and poor outcomes of breast cancer in Matabeleland South and the Bulawayo Metropolitan Provinces in Zimbabwe.
    PLoS One. 2023;18:e0292169.
    PubMed     Abstract available

  206. VON HIPPEL C, Dibble KE, Rosenberg SM, Bollman-Jenkins M, et al
    Taking their wellbeing into their own hands: Self-educated and peer-recommended techniques used by women with breast cancer to improve sexual functioning during treatment and in survivorship.
    PLoS One. 2023;18:e0293298.
    PubMed     Abstract available

  207. SATAGOPAN JM, Dharamdasani T, Mathur S, Kohler RE, et al
    Experiences and lessons learned from community-engaged recruitment for the South Asian breast cancer study in New Jersey during the COVID-19 pandemic.
    PLoS One. 2023;18:e0294170.
    PubMed     Abstract available

  208. ZAMANI N, Szymiczek A, Shakeri R, Poustchi H, et al
    A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.
    PLoS One. 2023;18:e0292611.
    PubMed     Abstract available

  209. HWANG HJ, Lee TG
    Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea.
    PLoS One. 2023;18:e0294649.
    PubMed     Abstract available

  210. BITTER EE, Skidmore J, Allen CI, Erickson RI, et al
    TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells.
    PLoS One. 2023;18:e0293128.
    PubMed     Abstract available

  211. ZHAO Y, Wang W, Li J, Du J, et al
    Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
    PLoS One. 2023;18:e0263710.
    PubMed     Abstract available

  212. DUBOWITZ J, Ziegler AI, Beare R, Jost-Brinkmann F, et al
    Type of anesthesia for cancer resection surgery: No differential impact on cancer recurrence in mouse models of breast cancer.
    PLoS One. 2023;18:e0293905.
    PubMed     Abstract available

  213. Retraction: Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating miR-34a.
    PLoS One. 2023;18:e0295991.

  214. PLANTE A, Gauvin L, Sabiston CM, Dore I, et al
    Perceived autonomy support from healthcare professionals and physical activity among breast cancer survivors: A propensity score analysis.
    PLoS One. 2023;18:e0295751.
    PubMed     Abstract available

  215. MOGHTADERI S, Mandapati A, Davies G, Wahid KA, et al
    Smart and low-cost fluorometer for identifying breast cancer malignancy based on lipid droplets accumulation.
    PLoS One. 2023;18:e0294988.
    PubMed     Abstract available

  216. YANG Y, Zhang Y, Tang Y, Zhang J, et al
    Anesthesia-related intervention for long-term survival and cancer recurrence following breast cancer surgery: A systematic review of prospective studies.
    PLoS One. 2023;18:e0296158.
    PubMed     Abstract available

  217. WANG P, Zhang Q, Zhang H, Shao J, et al
    Molecular and clinical characterization of ICOS expression in breast cancer through large-scale transcriptome data.
    PLoS One. 2023;18:e0293469.
    PubMed     Abstract available

  218. FONTANA F, Esser AK, Egbulefu C, Karmakar P, et al
    Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting.
    PLoS One. 2023;18:e0293700.
    PubMed     Abstract available

  219. Retraction: Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer.
    PLoS One. 2023;18:e0296553.

    January 2022
  220. MASCIA F, Mazo I, Alterovitz WL, Karagiannis K, et al
    In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines.
    PLoS One. 2022;17:e0262134.
    PubMed     Abstract available

  221. MOHAMED EA, Rashed EA, Gaber T, Karam O, et al
    Deep learning model for fully automated breast cancer detection system from thermograms.
    PLoS One. 2022;17:e0262349.
    PubMed     Abstract available

  222. HUTAJULU SH, Prabandari YS, Bintoro BS, Wiranata JA, et al
    Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study.
    PLoS One. 2022;17:e0262468.
    PubMed     Abstract available

  223. ZAHRAN AM, Rayan A, Zahran ZAM, Mohamed WMY, et al
    Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer.
    PLoS One. 2022;17:e0262650.
    PubMed     Abstract available

  224. HOZHABRI H, Ghasemi Dehkohneh RS, Razavi SM, Razavi SM, et al
    Comparative analysis of protein-protein interaction networks in metastatic breast cancer.
    PLoS One. 2022;17:e0260584.
    PubMed     Abstract available

  225. SILVA DAS
    Hospitalization and ambulatory costs related to breast cancer due to physical inactivity in the Brazilian state capitals.
    PLoS One. 2022;17:e0261019.
    PubMed     Abstract available

  226. CAO X, Li Y, Wang Y, Yu T, et al
    Curcumin suppresses tumorigenesis by ferroptosis in breast cancer.
    PLoS One. 2022;17:e0261370.
    PubMed     Abstract available

  227. MURAYAMA MA, Takada E, Takai K, Arimitsu N, et al
    Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells.
    PLoS One. 2022;17:e0260838.
    PubMed     Abstract available

  228. TOMAS RC, Sayat AJ, Atienza AN, Danganan JL, et al
    Detection of breast cancer by ATR-FTIR spectroscopy using artificial neural networks.
    PLoS One. 2022;17:e0262489.
    PubMed     Abstract available

  229. SHI D, Li H, Zhang Z, He Y, et al
    Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway.
    PLoS One. 2022;17:e0262389.
    PubMed     Abstract available

  230. HUSSAIN I, Majeed A, Masood I, Ashraf W, et al
    A national survey to assess breast cancer awareness among the female university students of Pakistan.
    PLoS One. 2022;17:e0262030.
    PubMed     Abstract available

  231. RAJAGOPAL T, Seshachalam A, Rathnam KK, Talluri S, et al
    Homologous recombination DNA repair gene RAD51, XRCC2 & XRCC3 polymorphisms and breast cancer risk in South Indian women.
    PLoS One. 2022;17:e0259761.
    PubMed     Abstract available

  232. LAZA-VASQUEZ C, Codern-Bove N, Cardona-Cardona A, Hernandez-Leal MJ, et al
    Views of health professionals on risk-based breast cancer screening and its implementation in the Spanish National Health System: A qualitative discussion group study.
    PLoS One. 2022;17:e0263788.
    PubMed     Abstract available

  233. TSUI TCO, Trudeau M, Mitsakakis N, Torres S, et al
    Developing the Breast Utility Instrument, a preference-based instrument to measure health-related quality of life in women with breast cancer: Confirmatory factor analysis of the EORTC QLQ-C30 and BR45 to establish dimensions.
    PLoS One. 2022;17:e0262635.
    PubMed     Abstract available

  234. MARQUES AD, Moura AR, Hora EC, Brito EAC, et al
    Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study.
    PLoS One. 2022;17:e0263222.
    PubMed     Abstract available

  235. HESARI E, Ahmadinezhad M, Arshadi M, Azizi H, et al
    The association between migraine and breast cancer risk: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263628.
    PubMed     Abstract available

  236. TSCHODU D, Ulm B, Bendrat K, Lippoldt J, et al
    Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature.
    PLoS One. 2022;17:e0261035.
    PubMed     Abstract available

  237. AKOKO LO, Rutashobya AK, Lutainulwa EW, Mwanga AH, et al
    The effect of reproductive, hormonal, nutritional and lifestyle on breast cancer risk among black Tanzanian women: A case control study.
    PLoS One. 2022;17:e0263374.
    PubMed     Abstract available

  238. KILBAS PO, Can ND, Kizilboga T, Ezberci F, et al
    CRISPR/Cas9-mediated Bag-1 knockout increased mesenchymal characteristics of MCF-7 cells via Akt hyperactivation-mediated actin cytoskeleton remodeling.
    PLoS One. 2022;17:e0261062.
    PubMed     Abstract available

  239. LV Z, Zhang W, Zhang Y, Zhong G, et al
    Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study.
    PLoS One. 2022;17:e0263104.
    PubMed     Abstract available

  240. PADMANABHAN H, Hassan NT, Wong SW, Lee YQ, et al
    Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
    PLoS One. 2022;17:e0263675.
    PubMed     Abstract available

  241. CONTE F, Sibilio P, Grimaldi AM, Salvatore M, et al
    In silico recognition of a prognostic signature in basal-like breast cancer patients.
    PLoS One. 2022;17:e0264024.
    PubMed     Abstract available

  242. MARKELLOS C, Ourailidou ME, Gavriatopoulou M, Halvatsiotis P, et al
    Olive oil intake and cancer risk: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0261649.
    PubMed     Abstract available

  243. NELSON DR, Brown J, Morikawa A, Method M, et al
    Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics.
    PLoS One. 2022;17:e0264637.
    PubMed     Abstract available

  244. TSAI CJ, Huang HY, Chen FM, Yang YH, et al
    Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ.
    PLoS One. 2022;17:e0262934.
    PubMed     Abstract available

  245. MAHMOOD T, Li J, Pei Y, Akhtar F, et al
    Breast lesions classifications of mammographic images using a deep convolutional neural network-based approach.
    PLoS One. 2022;17:e0263126.
    PubMed     Abstract available

  246. KWON D, Ko BK, Jung SP, Kim HK, et al
    Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population.
    PLoS One. 2022;17:e0262709.
    PubMed     Abstract available

  247. TROUGHTON LD, O'Loughlin DA, Zech T, Hamill KJ, et al
    Laminin N-terminus alpha31 is upregulated in invasive ductal breast cancer and changes the mode of tumour invasion.
    PLoS One. 2022;17:e0264430.
    PubMed     Abstract available

  248. KOLODZIEJ M, Kaznowska E, Paszek S, Cebulski J, et al
    Characterisation of breast cancer molecular signature and treatment assessment with vibrational spectroscopy and chemometric approach.
    PLoS One. 2022;17:e0264347.
    PubMed     Abstract available

  249. KIM H, Lee SB, Kim J, Chung IY, et al
    Improvement of survival in Korean breast cancer patients over a 14-year period: A large-scale single-center study.
    PLoS One. 2022;17:e0265533.
    PubMed     Abstract available

  250. XU X, Soulos PR, Herrin J, Wang SY, et al
    Perioperative magnetic resonance imaging in breast cancer care: Distinct adoption trajectories among physician patient-sharing networks.
    PLoS One. 2022;17:e0265188.
    PubMed     Abstract available

  251. SHI SC, Zhang Y, Wang T
    High RRM2 expression has poor prognosis in specific types of breast cancer.
    PLoS One. 2022;17:e0265195.
    PubMed     Abstract available

  252. ZHU J, Oh JH, Deasy JO, Tannenbaum AR, et al
    vWCluster: Vector-valued optimal transport for network based clustering using multi-omics data in breast cancer.
    PLoS One. 2022;17:e0265150.
    PubMed     Abstract available

  253. BOUJEMAA M, Mighri N, Chouchane L, Boubaker MS, et al
    Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population.
    PLoS One. 2022;17:e0265638.
    PubMed     Abstract available

  254. LIU J, Ho PJ, Tan THL, Yeoh YS, et al
    BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programme.
    PLoS One. 2022;17:e0265965.
    PubMed     Abstract available

  255. BOMMI-REDDY A, Park-Chouinard S, Mayhew DN, Terzo E, et al
    CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.
    PLoS One. 2022;17:e0262378.
    PubMed     Abstract available

  256. CHUAYCHAI A, Sriplung H
    A rapid rise in hormone receptor-positive and HER2-positive breast cancer subtypes in Southern Thai women: A population-based study in Songkhla.
    PLoS One. 2022;17:e0265417.
    PubMed     Abstract available

  257. ULLAH F, Khurshid N, Fatimi Q, Loidl P, et al
    Mutations in the acetylation hotspots of Rbl2 are associated with increased risk of breast cancer.
    PLoS One. 2022;17:e0266196.
    PubMed     Abstract available

  258. FLORES-GARCIA LC, Ventura-Gallegos JL, Romero-Cordoba SL, Hernandez-Juarez AJ, et al
    Sera from women with different metabolic and menopause states differentially regulate cell viability and Akt activation in a breast cancer in-vitro model.
    PLoS One. 2022;17:e0266073.
    PubMed     Abstract available

  259. PETROCCHI S, Ongaro G, Calvello M, Feroce I, et al
    A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.
    PLoS One. 2022;17:e0266327.
    PubMed     Abstract available

  260. FILIPOWICZ N, Drezek K, Horbacz M, Wojdak A, et al
    Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition.
    PLoS One. 2022;17:e0266111.
    PubMed     Abstract available

  261. ROJAS ROJAS T, Poizot-Martin I, Rey D, Duvivier C, et al
    Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
    PLoS One. 2022;17:e0261069.
    PubMed     Abstract available

  262. CHEN PC, Lee YC, Su YC, Lee CH, et al
    Does hepatectomy improve outcomes of breast cancer with liver metastasis? A nationwide analysis of real-world data in Taiwan.
    PLoS One. 2022;17:e0266960.
    PubMed     Abstract available

  263. PEREZ CS, Mestriner C, Ribeiro LTN, Grillo FW, et al
    Relationship between lymphedema after breast cancer treatment and biophysical characteristics of the affected tissue.
    PLoS One. 2022;17:e0264160.
    PubMed     Abstract available

  264. SQUARA PA, Luu VP, Perol D, Coudert B, et al
    Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France.
    PLoS One. 2022;17:e0267242.
    PubMed     Abstract available

  265. HU H, Qiao S, Hao Y, Bai Y, et al
    Breast cancer histopathological images recognition based on two-stage nuclei segmentation strategy.
    PLoS One. 2022;17:e0266973.
    PubMed     Abstract available

  266. NUNEZ-RUIZ A, Sanchez-Brena F, Lopez-Pacheco C, Acevedo-Dominguez NA, et al
    Obesity modulates the immune macroenvironment associated with breast cancer development.
    PLoS One. 2022;17:e0266827.
    PubMed     Abstract available

  267. AI H
    GSEA-SDBE: A gene selection method for breast cancer classification based on GSEA and analyzing differences in performance metrics.
    PLoS One. 2022;17:e0263171.
    PubMed     Abstract available

  268. DAILY A, Ravishankar P, Harms S, Klimberg VS, et al
    Using tears as a non-invasive source for early detection of breast cancer.
    PLoS One. 2022;17:e0267676.
    PubMed     Abstract available

  269. TZELVES L, Manolitsis I, Varkarakis I, Ivanovic M, et al
    Artificial intelligence supporting cancer patients across Europe-The ASCAPE project.
    PLoS One. 2022;17:e0265127.
    PubMed     Abstract available

  270. PARK SY, Kim JH, Chang JH, Park JM, et al
    Quantitative evaluation of radiodermatitis following whole-breast radiotherapy with various color space models: A feasibility study.
    PLoS One. 2022;17:e0264925.
    PubMed     Abstract available

  271. ARORA I, Sharma M, Li S, Crowley M, et al
    An integrated analysis of the effects of maternal broccoli sprouts exposure on transcriptome and methylome in prevention of offspring mammary cancer.
    PLoS One. 2022;17:e0264858.
    PubMed     Abstract available

  272. LOPEZ-JIMENEZ T, Duarte-Salles T, Plana-Ripoll O, Recalde M, et al
    Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study.
    PLoS One. 2022;17:e0264634.
    PubMed     Abstract available

  273. HAO Y, Zhang L, Qiao S, Bai Y, et al
    Breast cancer histopathological images classification based on deep semantic features and gray level co-occurrence matrix.
    PLoS One. 2022;17:e0267955.
    PubMed     Abstract available

  274. KOYAMA K, Ishikawa H, Abe M, Shiose Y, et al
    Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression.
    PLoS One. 2022;17:e0267027.
    PubMed     Abstract available

  275. LI T, Li Y, Yang Y, Li J, et al
    Logistic regression analysis of ultrasound findings in predicting the malignant and benign phyllodes tumor of breast.
    PLoS One. 2022;17:e0265952.
    PubMed     Abstract available

  276. UEDA D, Yamamoto A, Onoda N, Takashima T, et al
    Development and validation of a deep learning model for detection of breast cancers in mammography from multi-institutional datasets.
    PLoS One. 2022;17:e0265751.
    PubMed     Abstract available

  277. OSE N, Takeuchi Y, Sakamaki Y, Kadota Y, et al
    Detection of lymph node metastasis in non-small cell lung cancer using the new system of one-step nucleic acid amplification assay.
    PLoS One. 2022;17:e0265603.
    PubMed     Abstract available

  278. ANNONI AM, Longhini C
    Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.
    PLoS One. 2022;17:e0265387.
    PubMed     Abstract available

  279. TAGHIZADEH MS, Niazi A, Moghadam A, Afsharifar A, et al
    Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer.
    PLoS One. 2022;17:e0267961.
    PubMed     Abstract available

  280. DAMASCENO KA, Santos-Conceicao AMD, Silva LP, Cardoso TMS, et al
    Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma.
    PLoS One. 2022;17:e0267648.
    PubMed     Abstract available

  281. SCHLIEMANN D, Hoe WMK, Mohan D, Allotey P, et al
    Challenges and opportunities for breast cancer early detection among rural dwelling women in Segamat District, Malaysia: A qualitative study.
    PLoS One. 2022;17:e0267308.
    PubMed     Abstract available

  282. MEDINA HN, Callahan KE, Koru-Sengul T, Maheshwari S, et al
    Elevated breast cancer mortality among highly educated Asian American women.
    PLoS One. 2022;17:e0268617.
    PubMed     Abstract available

  283. MA L, Bian M, Gao H, Zhou Z, et al
    A novel 3-acyl isoquinolin-1(2H)-one induces G2 phase arrest, apoptosis and GSDME-dependent pyroptosis in breast cancer.
    PLoS One. 2022;17:e0268060.
    PubMed     Abstract available

  284. CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
    Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
    PLoS One. 2022;17:e0265881.
    PubMed     Abstract available

  285. ALAM MS, Sultana A, Reza MS, Amanullah M, et al
    Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
    PLoS One. 2022;17:e0268967.
    PubMed     Abstract available

  286. ZEMNI I, Kacem M, Dhouib W, Bennasrallah C, et al
    Breast cancer incidence and predictions (Monastir, Tunisia: 2002-2030): A registry-based study.
    PLoS One. 2022;17:e0268035.
    PubMed     Abstract available

  287. GRANT E, Bucklain FA, Ginn L, Laity P, et al
    Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines.
    PLoS One. 2022;17:e0268300.
    PubMed     Abstract available

  288. ONAGA C, Tamori S, Matsuoka I, Ozaki A, et al
    High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.
    PLoS One. 2022;17:e0268799.
    PubMed     Abstract available

  289. NGAN TT, Jenkins C, Minh HV, Donnelly M, et al
    Breast cancer screening practices among Vietnamese women and factors associated with clinical breast examination uptake.
    PLoS One. 2022;17:e0269228.
    PubMed     Abstract available

  290. TRAN T, Le U, Shi Y
    An effective up-sampling approach for breast cancer prediction with imbalanced data: A machine learning model-based comparative analysis.
    PLoS One. 2022;17:e0269135.
    PubMed     Abstract available

  291. NAM KH, Lee JH, Chung YS, Chun YS, et al
    The efficacy of oxidized regenerated cellulose (SurgiGuard(R)) in breast cancer patients who undergo total mastectomy with node surgery: A prospective randomized study in 94 patients.
    PLoS One. 2022;17:e0267694.
    PubMed     Abstract available

  292. MEURS CJC, Til JAV, Menke-Pluijmers MBE, Vet S, et al
    Surgeons' preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ.
    PLoS One. 2022;17:e0269551.
    PubMed     Abstract available

  293. TANDA N, Tada H, Washio J, Takahashi N, et al
    Influence of alcohol sensitivity on bone metastases and skeletal-related events in primary operable breast cancer: A retrospective cohort study.
    PLoS One. 2022;17:e0269335.
    PubMed     Abstract available

  294. XIA LY, Xu WY, Zhao Y
    Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
    PLoS One. 2022;17:e0270528.
    PubMed     Abstract available

  295. PUSPITANINGTYAS H, Sulistyoningrum DC, Witaningrum R, Widodo I, et al
    Vitamin D status in breast cancer cases following chemotherapy: A pre and post observational study in a tertiary hospital in Yogyakarta, Indonesia.
    PLoS One. 2022;17:e0270507.
    PubMed     Abstract available

  296. HARDEMAN AA, Han YJ, Grushko TA, Mueller J, et al
    Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer.
    PLoS One. 2022;17:e0268693.
    PubMed     Abstract available

  297. SILVA DA COSTA N, Alves da Silva AS, de Melo-Neto JS
    Effects of dance therapy in women with breast cancer: A systematic review protocol.
    PLoS One. 2022;17:e0257948.
    PubMed     Abstract available

  298. PIEMONTESE A, Galvain T, Swindells L, Parago V, et al
    Budget impact analysis of HARMONIC FOCUS+ Shears for mastectomy and breast-conserving surgery with axillary lymph node dissection compared with monopolar electrocautery from an Italian hospital perspective.
    PLoS One. 2022;17:e0268708.
    PubMed     Abstract available

  299. PARK J, Kim C, Ki Y, Kim W, et al
    Incidence of hypothyroidism after treatment for breast cancer: A Korean population-based study.
    PLoS One. 2022;17:e0269893.
    PubMed     Abstract available

  300. MENG X, Wang L, He M, Yang Z, et al
    Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
    PLoS One. 2022;17:e0269998.
    PubMed     Abstract available

  301. SARKER R, Islam MS, Moonajilin MS, Rahman M, et al
    Knowledge of breast cancer and breast self-examination practices and its barriers among university female students in Bangladesh: Findings from a cross-sectional study.
    PLoS One. 2022;17:e0270417.
    PubMed     Abstract available

  302. COX A, Martini A, Ghozlan H, Moroose R, et al
    Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood.
    PLoS One. 2022;17:e0264651.
    PubMed     Abstract available

  303. REME SE, Munk A, Holter MTS, Falk RS, et al
    Pre- and post-operative psychological interventions to prevent pain and fatigue after breast cancer surgery (PREVENT): Protocol for a randomized controlled trial.
    PLoS One. 2022;17:e0268606.
    PubMed     Abstract available

  304. MELLOR P, Kendall S, Smith S, Saxena A, et al
    Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.
    PLoS One. 2022;17:e0271090.
    PubMed     Abstract available

  305. CZUBAK-PROWIZOR K, Macieja A, Poplawski T, Zbikowska HM, et al
    Responses of human colon and breast adenocarcinoma cell lines (LoVo, MCF7) and non-tumorigenic mammary epithelial cells (MCF-10A) to the acellular fraction of packed red blood cells in the presence and absence of cisplatin.
    PLoS One. 2022;17:e0271193.
    PubMed     Abstract available

  306. MESSIER TL, Boyd JR, Gordon JAR, Tye CE, et al
    Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.
    PLoS One. 2022;17:e0271725.
    PubMed     Abstract available

  307. CONTI B, Bochaton A, Charreire H, Kitzis-Bonsang H, et al
    Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review.
    PLoS One. 2022;17:e0271319.
    PubMed     Abstract available

  308. DIOSAN L, Andreica A, Voiculescu I
    On the use of multi-objective evolutionary classifiers for breast cancer detection.
    PLoS One. 2022;17:e0269950.
    PubMed     Abstract available

  309. YANG Z, Liu J, Wang Q
    Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span.
    PLoS One. 2022;17:e0270347.
    PubMed     Abstract available

  310. ACEA-NEBRIL B, Garcia-Novoa A, Garcia Jimenez L
    The PreQ-20 TRIAL: A prospective cohort study of the oncologic safety, quality of life and cosmetic outcomes of patients undergoing prepectoral breast reconstruction.
    PLoS One. 2022;17:e0269426.
    PubMed     Abstract available

  311. FUNGA ML, Dilebo ZD, Shuramo AG, Bereku T, et al
    Assessing breast cancer awareness on reproductive age women in West Badewacho Woreda, Hadiyya Zone, South Ethiopia; Community based cross- sectional study.
    PLoS One. 2022;17:e0270248.
    PubMed     Abstract available

  312. CHEN CC, Ho WL, Lin CH, Chen HH, et al
    Stratified analysis of the association between periodontitis and female breast cancer based on age, comorbidities and level of urbanization: A population-based nested case-control study.
    PLoS One. 2022;17:e0271948.
    PubMed     Abstract available

  313. DEY M, Rana SP, Loretoni R, Duranti M, et al
    Automated breast lesion localisation in microwave imaging employing simplified pulse coupled neural network.
    PLoS One. 2022;17:e0271377.
    PubMed     Abstract available

  314. WANG J, Chen X, Wang L, Zhang C, et al
    Does aquatic physical therapy affect the rehabilitation of breast cancer in women? A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0272337.
    PubMed     Abstract available

  315. KHAJAH MA, Khushaish S, Luqmani YA
    Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
    PLoS One. 2022;17:e0272449.
    PubMed     Abstract available

  316. LAZAR IM, Karcini A, Haueis JRS
    Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks.
    PLoS One. 2022;17:e0272384.
    PubMed     Abstract available

  317. PE KCS, Saetung R, Yodsurang V, Chaotham C, et al
    Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.
    PLoS One. 2022;17:e0273044.
    PubMed     Abstract available

  318. YANG Y, Lin Y, Sikapokoo GO, Min SH, et al
    Social relationships and their associations with affective symptoms of women with breast cancer: A scoping review.
    PLoS One. 2022;17:e0272649.
    PubMed     Abstract available

  319. AYNALEM M, Adem N, Wendesson F, Misganaw B, et al
    Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center.
    PLoS One. 2022;17:e0271895.
    PubMed     Abstract available

  320. NISHI K, Fu W, Kiyama R
    Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity.
    PLoS One. 2022;17:e0273164.
    PubMed     Abstract available

  321. YANG K, Suzuki A, Ye J, Nosato H, et al
    CTG-Net: Cross-task guided network for breast ultrasound diagnosis.
    PLoS One. 2022;17:e0271106.
    PubMed     Abstract available

  322. HLAING MT, Horimoto Y, Denda-Nagai K, Fujihira H, et al
    Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin.
    PLoS One. 2022;17:e0273513.
    PubMed     Abstract available

  323. SLAGHMUYLDER Y, Pype P, Van Hecke A, Lauwerier E, et al
    Exploring healthcare providers' perceptions regarding the prevention and treatment of chronic pain in breast cancer survivors: A qualitative analysis among different disciplines.
    PLoS One. 2022;17:e0273576.
    PubMed     Abstract available

  324. BEAUBRUN-RENARD MM, Veronique-Baudin J, Macni J, Ulric-Gervaise S, et al
    Overall survival of triple negative breast cancer in French Caribbean women.
    PLoS One. 2022;17:e0271966.
    PubMed     Abstract available

  325. KEMBOI D, Langat MK, Siwe-Noundou X, Tshiwawa T, et al
    13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico.
    PLoS One. 2022;17:e0271389.
    PubMed     Abstract available

  326. Retraction: Vascular Endothelial Growth Factor Receptor-1 Activation Promotes Migration and Invasion of Breast Cancer Cells through Epithelial-Mesenchymal Transition.
    PLoS One. 2022;17:e0274216.

  327. VICENTE-MUNOZ S, Hunt BG, Lange TE, Wells SI, et al
    NMR-based metabolomic analysis identifies RON-DEK-beta-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
    PLoS One. 2022;17:e0274128.
    PubMed     Abstract available

  328. VAN GOGH S, Mukherjee S, Xu J, Wang Z, et al
    Iterative phase contrast CT reconstruction with novel tomographic operator and data-driven prior.
    PLoS One. 2022;17:e0272963.
    PubMed     Abstract available

  329. MEYER SB, Lunnay B, Warin M, Foley K, et al
    Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk.
    PLoS One. 2022;17:e0270936.
    PubMed     Abstract available

  330. MIGHRI N, Mejri N, Boujemaa M, Berrazega Y, et al
    Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients.
    PLoS One. 2022;17:e0269732.
    PubMed     Abstract available

  331. AL-SANEA MM, Chilingaryan G, Abelyan N, Mamikonyan M, et al
    Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors.
    PLoS One. 2022;17:e0272065.
    PubMed     Abstract available

  332. STAAF J, Aine M
    Tumor purity adjusted beta values improve biological interpretability of high-dimensional DNA methylation data.
    PLoS One. 2022;17:e0265557.
    PubMed     Abstract available

  333. LEE C, Kim S, Woo J
    A comparative analysis of factors influencing colorectal cancer's age standardized mortality ratio among Korean women in the hot and cold spots.
    PLoS One. 2022;17:e0273995.
    PubMed     Abstract available

  334. SUN D, Li C, Zhang F
    MicroRNA-206 suppresses growth and metastasis of breast cancer stem cells via blocking EVI-1-mediated CALR expression.
    PLoS One. 2022;17:e0274919.
    PubMed     Abstract available

  335. RAHPEIMA R, Lin CA
    Numerical study of magnetic hyperthermia ablation of breast tumor on an anatomically realistic breast phantom.
    PLoS One. 2022;17:e0274801.
    PubMed     Abstract available

    Perceptions and knowledge of breast cancer and breast self-examination among young adult women in southwest Ethiopia: Application of the health belief model.
    PLoS One. 2022;17:e0274935.
    PubMed     Abstract available

  337. ZHUANG L, Chen H, Zheng X, Wu S, et al
    Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case-control study.
    PLoS One. 2022;17:e0274570.
    PubMed     Abstract available

  338. MASSAFRA R, Comes MC, Bove S, Didonna V, et al
    A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification.
    PLoS One. 2022;17:e0274691.
    PubMed     Abstract available

  339. HAMID AB, Frank LE, Bouley RA, Petreaca RC, et al
    Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.
    PLoS One. 2022;17:e0273736.
    PubMed     Abstract available

  340. CROZIER M, Tubman J, Fifield BA, Ferraiuolo RM, et al
    Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells.
    PLoS One. 2022;17:e0274675.
    PubMed     Abstract available

  341. LEE R, Lee HB, Paeng JC, Choi H, et al
    Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer.
    PLoS One. 2022;17:e0275279.
    PubMed     Abstract available

  342. RODALLEC A, Vaghi C, Ciccolini J, Fanciullino R, et al
    Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic.
    PLoS One. 2022;17:e0274886.
    PubMed     Abstract available

  343. ROSERO G, Pattarone G, Penaherera A, Pilz J, et al
    Metronomic doses and drug schematic combination response tested within chambered coverslips for the treatment of breast cancer cells (JIMT-1).
    PLoS One. 2022;17:e0274911.
    PubMed     Abstract available

  344. IBRAHIM EY, Munshani S, Domenicano I, Rodwin R, et al
    A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy.
    PLoS One. 2022;17:e0275648.
    PubMed     Abstract available

  345. GOWTHAM HG, Murali M, Singh SB, Shivamallu C, et al
    Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular docking and conceptual DFT studies.
    PLoS One. 2022;17:e0275432.
    PubMed     Abstract available

  346. SAKAFU LL, Philipo GS, Malichewe CV, Fundikira LS, et al
    Delayed diagnostic evaluation of symptomatic breast cancer in sub-Saharan Africa: A qualitative study of Tanzanian women.
    PLoS One. 2022;17:e0275639.
    PubMed     Abstract available

  347. DEMEKE T, Ayele W, Haile Mariam D, Wienke A, et al
    Health system cost of breast cancer treatment in Addis Ababa, Ethiopia.
    PLoS One. 2022;17:e0275171.
    PubMed     Abstract available

  348. HARIKRISHNAN K, Prabhu SS, Balasubramanian N
    A pan-cancer analysis of matrisome proteins reveals CTHRC1 and a related network as major ECM regulators across cancers.
    PLoS One. 2022;17:e0270063.
    PubMed     Abstract available

  349. NAM KE, Kim I, Park HY, Lee JI, et al
    The effect of breast cancer surgery on spine alignment: Whole-spine radiograph analysis.
    PLoS One. 2022;17:e0276173.
    PubMed     Abstract available

  350. DE BONIFACE J, Altena R, Haddad Ringborg C, Bolam KA, et al
    Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial.
    PLoS One. 2022;17:e0274804.
    PubMed     Abstract available

  351. JAGARLAMUDI KK, L S, M Z, J O, et al
    Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
    PLoS One. 2022;17:e0275444.
    PubMed     Abstract available

  352. KIBRET YM, Leka YA, Tekle NF, Tigeneh W, et al
    Patterns of cancer in Wolaita Sodo University Hospital: South Ethiopia.
    PLoS One. 2022;17:e0274792.
    PubMed     Abstract available

  353. POKORA RM, Buttner M, Schulz A, Schuster AK, et al
    Determinants of mammography screening participation-a cross-sectional analysis of the German population-based Gutenberg Health Study (GHS).
    PLoS One. 2022;17:e0275525.
    PubMed     Abstract available

  354. A MOHAMED E, Gaber T, Karam O, Rashed EA, et al
    A Novel CNN pooling layer for breast cancer segmentation and classification from thermograms.
    PLoS One. 2022;17:e0276523.
    PubMed     Abstract available

  355. CHAN WY, Cheah WK, Ramli Hamid MT, Md Shah MN, et al
    Impact of preoperative magnetic resonance imaging on surgery and eligibility for intraoperative radiotherapy in early breast cancer.
    PLoS One. 2022;17:e0274385.
    PubMed     Abstract available

  356. LU J, Chen XM, Xie KH
    Effectiveness of nursing interventions on the sexual quality of life of patients with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0277221.
    PubMed     Abstract available

  357. MCDONALD JT, Ricks-Santi LJ
    Hereditary variants of unknown significance in African American women with breast cancer.
    PLoS One. 2022;17:e0273835.
    PubMed     Abstract available

  358. HAYAT F, Khan NU, Khan AU, Ahmad I, et al
    Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
    PLoS One. 2022;17:e0276813.
    PubMed     Abstract available

  359. Retraction: Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis.
    PLoS One. 2022;17:e0277500.

  360. SYED ALWI SM, Mazlan M, Mohd Taib NA, Che Din N, et al
    A Delphi technique toward the development of a cognitive intervention framework module for breast cancer survivors with cognitive impairment following chemotherapy.
    PLoS One. 2022;17:e0277056.
    PubMed     Abstract available

  361. CRUZ SJV, Ribeiro AKPL, Pinheiro MDCN, Carneiro VCCB, et al
    Five-year survival rate and prognostic factors in women with breast cancer treated at a reference hospital in the Brazilian Amazon.
    PLoS One. 2022;17:e0277194.
    PubMed     Abstract available

  362. XIE N, Shu Q, Wang Z, Huang X, et al
    ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members.
    PLoS One. 2022;17:e0274757.
    PubMed     Abstract available

  363. LEE YL, Islam T, Danaee M, Taib NA, et al
    A longitudinal study of physical activity among Malaysian breast cancer survivors.
    PLoS One. 2022;17:e0277982.
    PubMed     Abstract available

  364. HUTCHINGS HA, Remesh A
    An evaluation of the readability and visual appearance of online patient resources for fibroadenoma.
    PLoS One. 2022;17:e0277823.
    PubMed     Abstract available

  365. JACKSON C, Finikarides L, Freeman ALJ
    The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.
    PLoS One. 2022;17:e0275321.
    PubMed     Abstract available

  366. LUO J, Chen S, Chen J, Zhou Y, et al
    Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer.
    PLoS One. 2022;17:e0278270.
    PubMed     Abstract available

  367. SCHWARZ F, Arefian H, Hartmann M, Runnebaum I, et al
    Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
    PLoS One. 2022;17:e0278460.
    PubMed     Abstract available

  368. TOMSIC S, Zagar T, Mihor A, Mlakar M, et al
    Prognostic factors and outcomes in women with breast cancer in Slovenia in relation to step-wise implementation of organized screening.
    PLoS One. 2022;17:e0278384.
    PubMed     Abstract available

  369. KIKAWA Y, Hagiwara Y, Fujisawa T, Araki K, et al
    Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy.
    PLoS One. 2022;17:e0278344.
    PubMed     Abstract available

  370. AMEEN F, AlNAdhari S, Al-Homaidan AA
    Marine fungi showing multifunctional activity against human pathogenic microbes and cancer.
    PLoS One. 2022;17:e0276926.
    PubMed     Abstract available

  371. TUCKER JD, Doddapaneni R, Lu PJ, Lu QL, et al
    Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer.
    PLoS One. 2022;17:e0278711.
    PubMed     Abstract available

  372. LANKREW AYALEW T, Wale BG, Haile KE, Zewudie BT, et al
    Health-related quality of life and associated factors among cancer patients in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2022;17:e0277839.
    PubMed     Abstract available

  373. GUNDOGMUS AG, Sezer Katar K, Orsel S, Ozturk G, et al
    The relationship of potential biomarkers with psychological resilience and post-traumatic growth in female patients with breast cancer.
    PLoS One. 2022;17:e0277119.
    PubMed     Abstract available

  374. ZHANG S, Wang H, Liu B, Yu J, et al
    Socioeconomic status index is an independent determinant of breast cancer screening practices: Evidence from Eastern China.
    PLoS One. 2022;17:e0279107.
    PubMed     Abstract available

  375. CHOUPANI E, Madjd Z, Saraygord-Afshari N, Kiani J, et al
    Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells.
    PLoS One. 2022;17:e0279522.
    PubMed     Abstract available

  376. QI SA, Kumar N, Xu JY, Patel J, et al
    Personalized breast cancer onset prediction from lifestyle and health history information.
    PLoS One. 2022;17:e0279174.
    PubMed     Abstract available

  377. LING AY, Jreich R, Montez-Rath ME, Meng Z, et al
    Transporting observational study results to a target population of interest using inverse odds of participation weighting.
    PLoS One. 2022;17:e0278842.
    PubMed     Abstract available

  378. TAHTAMOUNI L, Alzghoul A, Alderfer S, Sun J, et al
    The role of activated androgen receptor in cofilin phospho-regulation depends on the molecular subtype of TNBC cell line and actin assembly dynamics.
    PLoS One. 2022;17:e0279746.
    PubMed     Abstract available

  379. DUTTA D, Sen A, Satagopan J
    Sparse canonical correlation to identify breast cancer related genes regulated by copy number aberrations.
    PLoS One. 2022;17:e0276886.
    PubMed     Abstract available

  380. PREMACHANDRA A, Wang X, Saad M, Moussawy S, et al
    Erector spinae plane block versus thoracic paravertebral block for the prevention of acute postsurgical pain in breast cancer surgery: A prospective observational study compared with a propensity score-matched historical cohort.
    PLoS One. 2022;17:e0279648.
    PubMed     Abstract available

    January 2021
  381. HADJIPANTELI A, Polyviou P, Kyriakopoulos I, Genagritis M, et al
    Comparison of two-view versus single-view digital breast tomosynthesis and 2D-mammography in breast cancer surveillance imaging.
    PLoS One. 2021;16:e0256514.
    PubMed     Abstract available

  382. SANI L, Vispa A, Loretoni R, Duranti M, et al
    Breast lesion detection through MammoWave device: Empirical detection capability assessment of microwave images' parameters.
    PLoS One. 2021;16:e0250005.
    PubMed     Abstract available

  383. JARM K, Kadivec M, Sval C, Hertl K, et al
    Quality assured implementation of the Slovenian breast cancer screening programme.
    PLoS One. 2021;16:e0258343.
    PubMed     Abstract available

  384. SAKSORNCHAI K, Jaruthien T, Nantavithya C, Shotelersuk K, et al
    Long-term results of hypofractionation with concomitant boost in patients with early breast cancer: A prospective study.
    PLoS One. 2021;16:e0258186.
    PubMed     Abstract available

  385. GARCIA MT, Mota BS, Cardoso N, Martimbianco ALC, et al
    Accuracy of frozen section in intraoperative margin assessment for breast-conserving surgery: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248768.
    PubMed     Abstract available

  386. XIE Y, Guo B, Zhang R
    Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation.
    PLoS One. 2021;16:e0248220.
    PubMed     Abstract available

  387. MOHAMED RI, Bargal SA, Mekawy AS, El-Shiekh I, et al
    The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.
    PLoS One. 2021;16:e0247837.
    PubMed     Abstract available

  388. PARK JH, Jung YS, Kim JY, Bae SH, et al
    Determinants of quality of life in women immediately following the completion of primary treatment of breast cancer: A cross-sectional study.
    PLoS One. 2021;16:e0258447.
    PubMed     Abstract available

  389. STONE JK, Vukadin L, Ahn EE
    eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression.
    PLoS One. 2021;16:e0251515.
    PubMed     Abstract available

  390. ZOELLER JJ, Press MF, Selfors LM, Dering J, et al
    Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy.
    PLoS One. 2021;16:e0251163.
    PubMed     Abstract available

  391. BLASI MA, Maceroni M, Caputo CG, Sammarco MG, et al
    Clinical and ultrasonographic features of choroidal metastases based on primary cancer site: Long-term experience in a single center.
    PLoS One. 2021;16:e0249210.
    PubMed     Abstract available

  392. JAMES JE, Riddle L, Koenig BA, Joseph G, et al
    The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.
    PLoS One. 2021;16:e0258571.
    PubMed     Abstract available

  393. OPOKU F, Bedu-Addo K, Titiloye NA, Atta Manu E, et al
    Expression profile of tumour suppressor protein p53 and its regulator MDM2 in a cohort of breast cancer patients in a Tertiary Hospital in Ghana.
    PLoS One. 2021;16:e0258543.
    PubMed     Abstract available

  394. JENSEN MD, Hansen KM, Siersma V, Brodersen J, et al
    Using a Deliberative Poll on breast cancer screening to assess and improve the decision quality of laypeople.
    PLoS One. 2021;16:e0258869.
    PubMed     Abstract available

  395. BROCK EJ, Jackson RM, Boerner JL, Li Q, et al
    Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma.
    PLoS One. 2021;16:e0252314.
    PubMed     Abstract available

  396. AGODIRIN O, Olatoke S, Rahman G, Kolawole O, et al
    Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria.
    PLoS One. 2021;16:e0256847.
    PubMed     Abstract available

  397. MARES AG, Pacassoni G, Marti JS, Pujals S, et al
    Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology.
    PLoS One. 2021;16:e0251821.
    PubMed     Abstract available

  398. AMIRFALLAH A, Knutsdottir H, Arason A, Hilmarsdottir B, et al
    Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.
    PLoS One. 2021;16:e0260327.
    PubMed     Abstract available

  399. QIU P, Guo Q, Yao Q, Chen J, et al
    Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    PLoS One. 2021;16:e0254283.
    PubMed     Abstract available

  400. HANSEN JA, Naghavi-Behzad M, Gerke O, Baun C, et al
    Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
    PLoS One. 2021;16:e0260066.
    PubMed     Abstract available

  401. WU WP, Chen CY, Lee CW, Wu HK, et al
    Impact of pre-operative breast magnetic resonance imaging on contralateral synchronous and metachronous breast cancer detection-A case control comparison study with 1468 primary operable breast cancer patients with mean follow-up of 102 months.
    PLoS One. 2021;16:e0260093.
    PubMed     Abstract available

  402. DARGA EP, Dolce EM, Fang F, Kidwell KM, et al
    PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
    PLoS One. 2021;16:e0260124.
    PubMed     Abstract available

  403. MEKONEN S, Ibrahim M, Astatkie H, Abreha A, et al
    Correction: Exposure to organochlorine pesticides as a predictor to breast cancer: A case-control study among Ethiopian women.
    PLoS One. 2021;16:e0260106.
    PubMed     Abstract available

  404. EZZALFANI M, Porcher R, Savignoni A, Delaloge S, et al
    Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project.
    PLoS One. 2021;16:e0255017.
    PubMed     Abstract available

  405. KAGAYA Y, Arikawa M, Sekiyama T, Mitsuwa H, et al
    The concept of "whole perforator system" in the lateral thoracic region for latissimus dorsi muscle-preserving large flaps: An anatomical study and case series.
    PLoS One. 2021;16:e0256962.
    PubMed     Abstract available

  406. PRATOOMCHART C, Klunklin P, Wanwilairat S, Nobnop W, et al
    The advantages of abdominal compression with shallow breathing during left-sided postmastectomy radiotherapy by Helical TomoTherapy.
    PLoS One. 2021;16:e0254934.
    PubMed     Abstract available

  407. HE Q, Cheng G, Ju H
    BCDnet: Parallel heterogeneous eight-class classification model of breast pathology.
    PLoS One. 2021;16:e0253764.
    PubMed     Abstract available

  408. GUO Y, Duan X, Wang C, Guo H, et al
    Segmentation and recognition of breast ultrasound images based on an expanded U-Net.
    PLoS One. 2021;16:e0253202.
    PubMed     Abstract available

  409. GHANBARI S, Salimi A, Rahmani S, Nafissi N, et al
    miR-361-5p as a promising qRT-PCR internal control for tumor and normal breast tissues.
    PLoS One. 2021;16:e0253009.
    PubMed     Abstract available

  410. HARTMANN B, Muller M, Seyler L, Bauerle T, et al
    Feasibility of deuterium magnetic resonance spectroscopy of 3-O-Methylglucose at 7 Tesla.
    PLoS One. 2021;16:e0252935.
    PubMed     Abstract available

  411. EASLEY TO, Ren Z, Kim B, Karczmar GS, et al
    Enhancement-constrained acceleration: A robust reconstruction framework in breast DCE-MRI.
    PLoS One. 2021;16:e0258621.
    PubMed     Abstract available

  412. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed     Abstract available

  413. BRUCKMANN NM, Kirchner J, Morawitz J, Umutlu L, et al
    Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.
    PLoS One. 2021;16:e0260804.
    PubMed     Abstract available

  414. ADEYEMI OJ, Gill TL, Paul R, Huber LB, et al
    Evaluating the association of self-reported psychological distress and self-rated health on survival times among women with breast cancer in the U.S.
    PLoS One. 2021;16:e0260481.
    PubMed     Abstract available

  415. CHOI W, Lee H
    Identifying disease-gene associations using a convolutional neural network-based model by embedding a biological knowledge graph with entity descriptions.
    PLoS One. 2021;16:e0258626.
    PubMed     Abstract available

  416. ALACHRAM H, Chereda H, Beissbarth T, Wingender E, et al
    Text mining-based word representations for biomedical data analysis and protein-protein interaction networks in machine learning tasks.
    PLoS One. 2021;16:e0258623.
    PubMed     Abstract available

  417. SHAMMOUT ODA, Ashmawy NS, Shakartalla SB, Altaie AM, et al
    Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells.
    PLoS One. 2021;16:e0258363.
    PubMed     Abstract available

  418. KEETILE M, Ndlovu K, Letamo G, Disang M, et al
    Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
    PLoS One. 2021;16:e0255581.
    PubMed     Abstract available

  419. LENG X, Huang G, Li S, Yao M, et al
    Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS).
    PLoS One. 2021;16:e0261138.
    PubMed     Abstract available

  420. SON Y, Han K, Lee YS, Yu J, et al
    Privacy-preserving breast cancer recurrence prediction based on homomorphic encryption and secure two party computation.
    PLoS One. 2021;16:e0260681.
    PubMed     Abstract available

  421. POLITI MC, Saunders CH, Grabinski VF, Yen RW, et al
    An absence of equipoise: Examining surgeons' decision talk during encounters with women considering breast cancer surgery.
    PLoS One. 2021;16:e0260704.
    PubMed     Abstract available

  422. ZHOU Z, Li J, Wang H, Luan Z, et al
    Upper limb rehabilitation system based on virtual reality for breast cancer patients: Development and usability study.
    PLoS One. 2021;16:e0261220.
    PubMed     Abstract available

  423. FOMITCHEVA-KHARTCHENKO A, Rapsomaniki MA, Sobottka B, Schraml P, et al
    Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity.
    PLoS One. 2021;16:e0259332.
    PubMed     Abstract available

  424. ZIMMERMANN RC, Sardiu ME, Manton CA, Miah MS, et al
    Perturbation of BRMS1 interactome reveals pathways that impact metastasis.
    PLoS One. 2021;16:e0259128.
    PubMed     Abstract available

  425. SUN Y, Ji Y
    AAWS-Net: Anatomy-aware weakly-supervised learning network for breast mass segmentation.
    PLoS One. 2021;16:e0256830.
    PubMed     Abstract available

  426. BREDNO J, Lipson J, Venn O, Aravanis AM, et al
    Clinical correlates of circulating cell-free DNA tumor fraction.
    PLoS One. 2021;16:e0256436.
    PubMed     Abstract available

  427. HE X, Anthony DC, Catoni Z, Cao W, et al
    Pulmonary tumor embolism: A retrospective study over a 30-year period.
    PLoS One. 2021;16:e0255917.
    PubMed     Abstract available

  428. LIN KH, Hsu HM, Hsu KF, Chu CH, et al
    Survival outcomes in elderly Taiwanese women according to breast cancer subtype and lymph node status: A single-center retrospective study.
    PLoS One. 2021;16:e0261258.
    PubMed     Abstract available

  429. HU Y, Zou D
    Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
    PLoS One. 2021;16:e0260811.
    PubMed     Abstract available

  430. AWODUTIRE PO, Balogun OS, Olapade AK, Nduka EC, et al
    The modified beta transmuted family of distributions with applications using the exponential distribution.
    PLoS One. 2021;16:e0258512.
    PubMed     Abstract available

  431. CHANG YY, Lin HJ, Hsiao LC, Lin YF, et al
    Reduction of breast tumor drug resistance by 2,3,5,4'-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect.
    PLoS One. 2021;16:e0260533.
    PubMed     Abstract available

  432. TANAKA M, Tanaka T, Takamatsu M, Shibue C, et al
    Effects of the Kampo medicine Yokukansan for perioperative anxiety and postoperative pain in women undergoing breast surgery: A randomized, controlled trial.
    PLoS One. 2021;16:e0260524.
    PubMed     Abstract available

  433. KAUR P, Nagar S, Bhagwat M, Uddin M, et al
    Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells.
    PLoS One. 2021;16:e0260400.
    PubMed     Abstract available

  434. ZHANG X, Kschischo M
    MFmap: A semi-supervised generative model matching cell lines to tumours and cancer subtypes.
    PLoS One. 2021;16:e0261183.
    PubMed     Abstract available

  435. OZGENCIL M, Barwell J, Tischkowitz M, Izatt L, et al
    Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance.
    PLoS One. 2021;16:e0260852.
    PubMed     Abstract available

  436. HIRAMOTO S, Asano H, Miyamoto T, Takegami M, et al
    Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
    PLoS One. 2021;16:e0261473.
    PubMed     Abstract available

  437. VELAZQUEZ FN, Zhang L, Viscardi V, Trocchia C, et al
    Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
    PLoS One. 2021;16:e0252311.
    PubMed     Abstract available

  438. KIM HS, Kim MG, Min KW, Jung US, et al
    High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
    PLoS One. 2021;16:e0252052.
    PubMed     Abstract available

  439. BADAWY SM, Mohamed AEA, Hefnawy AA, Zidan HE, et al
    Automatic semantic segmentation of breast tumors in ultrasound images based on combining fuzzy logic and deep learning-A feasibility study.
    PLoS One. 2021;16:e0251899.
    PubMed     Abstract available

  440. HOLTDIRK F, Mehnert A, Weiss M, Mayer J, et al
    Results of the Optimune trial: A randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors.
    PLoS One. 2021;16:e0251276.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.